Articles

More than ‘skin-deep’ success

Corium posts top-line interim results of transdermal Alzheimer’s patch for once- weekly dosing
Written byKelsey Kaustinen
| 3 min read

MENLO PARK, Calif.—In its ongoing work of developing and commercializing specialty transdermal products, Corium International Inc. shared positive news recently, with top-line interim results from a Phase 1 clinical study of its Corplex Donepezil transdermal delivery system for the treatment of mild, moderate and severe dementia of the Alzheimer’s type. This product candidate is meant to offer an alternative for sustained, controlled drug delivery in a convenient, once-weekly dosage form.

Corium’s Corplex system is a novel commercial-stage platform technology designed to enable transdermal delivery of small molecules, many of which have not previously been suitable for that delivery method. The company’s transdermal and transmucosal systems are adaptable for use in a variety of drug categories and indications, and they could reduce the amount of active ingredient needed in transdermal products. The transdermal patches can enable efficient drug delivery, and stick to either wet or dry surfaces for an extended period of time.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.